Biotech Conferences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

NEW HAVEN, Conn., May 02, 2024 Arvinas, Inc. , a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that management will.

Jeff boyleNoah berkowitzKathleen murphyLas vegasArvinas incChief medical officerRandy teelChief business officerBiotech conferencesDiscovery engine